Coralie Cavallaro

Coralie Cavallaro is a Global Product Manager at Medacta International since 2016. Prior experience includes a brief stage at IRB Bellinzona, where Coralie conducted research on the analysis of the TP53 tumor suppressor gene mutation in anaplastic large cell lymphoma. Coralie holds educational credentials from Università degli Studi dell'Insubria.